{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:17:33Z","timestamp":1770481053697,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics & Development"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.gde.2010.12.007","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T04:31:33Z","timestamp":1295497893000},"page":"349-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Genetic modifiers of neurological disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Jennifer A","family":"Kearney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2010.12.007_bib0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00335-005-0049-4","article-title":"Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a","volume":"16","author":"Bergren","year":"2005","journal-title":"Mamm Genome"},{"key":"10.1016\/j.gde.2010.12.007_bib0010_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00335-009-9193-6","article-title":"Fine mapping of an epilepsy modifier gene on mouse Chromosome 19","volume":"20","author":"Bergren","year":"2009","journal-title":"Mamm Genome"},{"key":"10.1016\/j.gde.2010.12.007_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0888-7543(03)00152-6","article-title":"High-resolution mapping of the sodium channel modifier Scnm1 on mouse chromosome 3 and identification of a 1.3-kb recombination hot spot","volume":"82","author":"Buchner","year":"2003","journal-title":"Genomics"},{"key":"10.1016\/j.gde.2010.12.007_bib0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1086187","article-title":"SCNM1, a putative RNA splicing factor that modifies disease severity in mice","volume":"301","author":"Buchner","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.gde.2010.12.007_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10048-004-0175-2","article-title":"Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16","volume":"5","author":"Djousse","year":"2004","journal-title":"Neurogenetics"},{"key":"10.1016\/j.gde.2010.12.007_bib0030","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/hmg\/ddl034","article-title":"Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase","volume":"15","author":"Huang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1006\/geno.2000.6379","article-title":"Genetic mapping of a mouse modifier gene that can prevent ALS onset","volume":"70","author":"Kunst","year":"2000","journal-title":"Genomics"},{"key":"10.1016\/j.gde.2010.12.007_bib0040","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/378133","article-title":"A genome scan for modifiers of age at onset in Huntington disease: the HD MAPS study","volume":"73","author":"Li","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0045","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/hmg\/ddl125","article-title":"Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice","volume":"15","author":"Lloret","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00439-006-0221-2","article-title":"Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease","volume":"120","author":"Metzger","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10048-005-0023-z","article-title":"The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease","volume":"7","author":"Metzger","year":"2006","journal-title":"Neurogenetics"},{"key":"10.1016\/j.gde.2010.12.007_bib0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/ddn003","article-title":"Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease","volume":"17","author":"Metzger","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/hmg\/8.3.471","article-title":"Dystonia associated with mutation of the neuronal sodium channel Scn8a and identification of the modifier locus Scnm1 on mouse chromosome 3","volume":"8","author":"Sprunger","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00001756-200203250-00035","article-title":"Genetic modifiers that aggravate the neurological phenotype of the wobbler mouse","volume":"13","author":"Ulbrich","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.gde.2010.12.007_bib0075","doi-asserted-by":"crossref","first-page":"17576","DOI":"10.1074\/jbc.271.29.17576","article-title":"Mutation detection in the med and medJ alleles of the sodium channel Scn8a, Unusual splicing due to a minor class AT-AC intron","volume":"271","author":"Kohrman","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gde.2010.12.007_bib0080","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/hmg\/11.22.2765","article-title":"Molecular and pathological effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6)","volume":"11","author":"Kearney","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0085_1","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1093\/hmg\/ddm206","article-title":"Evidence for a direct role of the disease modifier SCNM1 in splicing","volume":"16","author":"Howell","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0090","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1534\/genetics.108.094227","article-title":"A targeted deleterious allele of the splicing factor SCNM1 in the mouse","volume":"180","author":"Howell","year":"2008","journal-title":"Genetics"},{"key":"10.1016\/j.gde.2010.12.007_bib0095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.tig.2005.07.005","article-title":"The splicing machinery is a genetic modifier of disease severity","volume":"21","author":"Nissim-Rafinia","year":"2005","journal-title":"Trends Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/gm13","article-title":"The Human Gene Mutation Database: 2008 update","volume":"1","author":"Stenson","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.gde.2010.12.007_bib0105_1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gde.2010.12.007_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng0198-19","article-title":"Experimental strategies for the genetic dissection of complex traits in animal models","volume":"18","author":"Darvasi","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg1576","article-title":"Strategies for mapping and cloning quantitative trait genes in rodents","volume":"6","author":"Flint","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0120","doi-asserted-by":"crossref","first-page":"12389","DOI":"10.1073\/pnas.240463597","article-title":"From mouse to human: fine mapping of quantitative trait loci in a model organism","volume":"97","author":"McPeek","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2010.12.007_bib0125","first-page":"199","article-title":"Experimental designs for QTL fine mapping in rodents","volume":"195","author":"Shalom","year":"2002","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.gde.2010.12.007_bib0130_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/gm80","article-title":"Huntington's disease: the case for genetic modifiers","volume":"1","author":"Gusella","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/j.gde.2010.12.007_bib0135","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00335-008-9130-0","article-title":"Functional genomics approaches to neurodegenerative diseases","volume":"19","author":"Rubinsztein","year":"2008","journal-title":"Mamm Genome"},{"key":"10.1016\/j.gde.2010.12.007_bib0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.a.20190","article-title":"Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease","volume":"119A","author":"Djousse","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.gde.2010.12.007_bib0145","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2010.12.007_bib0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.gde.2010.12.007_bib0155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0160_1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1242\/dmm.002527","article-title":"An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy","volume":"2","author":"Achilli","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.gde.2010.12.007_bib0165","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/hmg\/6.11.1951","article-title":"Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice","volume":"6","author":"Carlson","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2005.02.006","article-title":"Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS","volume":"236","author":"Heiman-Patterson","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.gde.2010.12.007_bib0175","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/hmg\/ddh210","article-title":"Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression","volume":"13","author":"Krezowski","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0180","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/hmg\/9.5.779","article-title":"Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus","volume":"9","author":"Lorenzetti","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0185","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1073\/pnas.0409598102","article-title":"Parkin-deficient mice are not a robust model of parkinsonism","volume":"102","author":"Perez","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2010.12.007_bib0190","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/ddl067","article-title":"Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans","volume":"15","author":"Kraemer","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0195","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1073\/pnas.0307697101","article-title":"Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation","volume":"101","author":"Nollen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2010.12.007_bib0200","doi-asserted-by":"crossref","first-page":"e1000027","DOI":"10.1371\/journal.pgen.1000027","article-title":"C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging","volume":"4","author":"van Ham","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0205_1","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1073\/pnas.0813045106","article-title":"Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2010.12.007_bib0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.gde.2010.12.007_bib0215","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng1542","article-title":"A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease","volume":"37","author":"Giorgini","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0220","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1126\/science.1090389","article-title":"Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein","volume":"302","author":"Willingham","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.gde.2010.12.007_bib0225_1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.337","article-title":"Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity","volume":"41","author":"Yeger-Lotem","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0230_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/emmm.200900051","article-title":"Neurodegenerative diseases: lessons from genome-wide screens in small model organisms","volume":"1","author":"van Ham","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.gde.2010.12.007_bib0235_1","doi-asserted-by":"crossref","first-page":"12168","DOI":"10.1073\/pnas.0903134106","article-title":"Genetic screen identifies serpin5 as a regulator of the toll pathway and CHMP2B toxicity associated with frontotemporal dementia","volume":"106","author":"Ahmad","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2010.12.007_bib0240","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/hmg\/ddm315","article-title":"Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases","volume":"17","author":"Branco","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0245_1","article-title":"Defining genetic factors that modulate intergenerational CAG repeat instability in Drosophila melanogaster","author":"Jung","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/j.gde.2010.12.007_bib0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","article-title":"VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death","volume":"34","author":"Lambrechts","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0255","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/hmg\/ddl019","article-title":"Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2","volume":"15","author":"Kearney","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2010.12.007_bib0260","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/nn1999","article-title":"Masking epilepsy by combining two epilepsy genes","volume":"10","author":"Glasscock","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gde.2010.12.007_bib0265","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1073\/pnas.0401496101","article-title":"Suppressor screen in Mpl\u2212\/\u2212 mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling","volume":"101","author":"Carpinelli","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gde.2010.12.007_bib0270_1","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1093\/hmg\/ddn110","article-title":"A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy","volume":"17","author":"Matera","year":"2008","journal-title":"Hum Mol Genet"}],"container-title":["Current Opinion in Genetics & Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X10002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X10002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:39:07Z","timestamp":1760701147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X10002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0959437X10002029"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2010.12.007","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic modifiers of neurological disease","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2010.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}